德康醫療
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
(Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -32.04%2,211.9萬 | 206.67%2,132萬 | 8.06%3,220.4萬 | 6.77%1.01億 | 134.57%3,178.7萬 | -19.87%3,254.5萬 | -3.58%695.2萬 | -10.49%2,980.3萬 | -43.63%9,467.3萬 | -60.69%1,355.1萬 |
淨利息收入 | -10.43%2,976.8萬 | -2.74%3,209.4萬 | 7.00%3,408.6萬 | 5.56%1.32億 | 11.54%3,372.1萬 | -10.55%3,323.5萬 | 22.99%3,299.7萬 | 3.93%3,185.5萬 | 20.03%1.25億 | 18.64%3,023.2萬 |
-利息收入總計 | -9.34%4,665萬 | -4.25%4,871萬 | 5.72%5,194.9萬 | 20.55%2.04億 | 10.71%5,205.6萬 | 5.78%5,145.7萬 | 43.66%5,087萬 | 30.17%4,913.6萬 | 25.26%1.69億 | 35.56%4,702.1萬 |
-利息費用總計 | -7.35%1,688.2萬 | -7.03%1,661.6萬 | 3.37%1,786.3萬 | 63.12%7,171.1萬 | 9.21%1,833.5萬 | 58.58%1,822.2萬 | 108.26%1,787.3萬 | 143.43%1,728.1萬 | 42.95%4,396.1萬 | 82.41%1,678.9萬 |
非利息收入總計 | -1,008.55%-764.9萬 | 58.63%-1,077.4萬 | 8.28%-188.2萬 | -1.76%-3,072.1萬 | 88.41%-193.4萬 | -119.93%-69萬 | -32.76%-2,604.5萬 | -177.55%-205.2萬 | -147.22%-3,019.1萬 | -285.53%-1,668.1萬 |
-傭金收入 | 7.29%-1,169.1萬 | 4.52%-1,220.1萬 | -0.37%-1,275.5萬 | -1.83%-5,113.7萬 | -3.05%-1,304.1萬 | 8.04%-1,261萬 | -10.43%-1,277.8萬 | -3.50%-1,270.8萬 | -9.11%-5,021.7萬 | -7.19%-1,265.5萬 |
-分紅收入 | 0.00%827.6萬 | 6.10%878.1萬 | 0.00%827.6萬 | 7.31%3,310.4萬 | 0.00%827.6萬 | 9.99%827.6萬 | 9.99%827.6萬 | 9.99%827.6萬 | 2.61%3,084.8萬 | 9.99%827.6萬 |
信貸損失準備金 | ||||||||||
非利息費用 | ||||||||||
銷售和管理費用 | 2.93%175.8萬 | 0.50%159.7萬 | 63.19%211萬 | -11.59%637.2萬 | -0.56%178.2萬 | -9.68%170.8萬 | -10.78%158.9萬 | -25.82%129.3萬 | 5.54%720.7萬 | 10.89%179.2萬 |
-管理費用 | 2.93%175.8萬 | 0.50%159.7萬 | 63.19%211萬 | -11.59%637.2萬 | -0.56%178.2萬 | -9.68%170.8萬 | -10.78%158.9萬 | -25.82%129.3萬 | 5.54%720.7萬 | 10.89%179.2萬 |
來自聯營公司及其他參與權益的收入(虧損) | ||||||||||
特殊收入(費用) | ||||||||||
其他非經營收入(費用) | ||||||||||
除稅前利潤 | -33.97%2,036.1萬 | 267.76%1,972.3萬 | 5.56%3,009.4萬 | 8.29%9,471.5萬 | 125.43%3,000.5萬 | -19.44%3,083.7萬 | 10.78%536.3萬 | -8.14%2,851萬 | -45.72%8,746.6萬 | -61.21%1,331萬 |
所得稅 | -11.76%75萬 | 50.31%97.7萬 | 58.70%83萬 | 33.13%243.5萬 | -51.59%41.2萬 | 89.31%85萬 | 269.32%65萬 | 48.16%52.3萬 | 133.89%182.9萬 | 139.04%85.1萬 |
除稅後的權益收益 | ||||||||||
除稅後利潤 | -34.60%1,961.1萬 | 297.75%1,874.6萬 | 4.56%2,926.4萬 | 7.76%9,228萬 | 137.52%2,959.3萬 | -20.73%2,998.7萬 | 1.03%471.3萬 | -8.79%2,798.7萬 | -46.59%8,563.7萬 | -63.31%1,245.9萬 |
持續經營利潤 | -34.60%1,961.1萬 | 297.75%1,874.6萬 | 4.56%2,926.4萬 | 7.76%9,228萬 | 137.52%2,959.3萬 | -20.73%2,998.7萬 | 1.03%471.3萬 | -8.79%2,798.7萬 | -46.59%8,563.7萬 | -63.31%1,245.9萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -34.60%1,961.1萬 | 297.75%1,874.6萬 | 4.56%2,926.4萬 | 7.76%9,228萬 | 137.52%2,959.3萬 | -20.73%2,998.7萬 | 1.03%471.3萬 | -8.79%2,798.7萬 | -46.59%8,563.7萬 | -63.31%1,245.9萬 |
優先股派息 | 0.00%87.5萬 | 0.00%87.5萬 | 0.00%87.5萬 | 0.00%350萬 | 0.00%87.5萬 | 0.00%87.5萬 | 0.00%87.5萬 | 0.00%87.5萬 | 0.00%350萬 | 0.00%87.5萬 |
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -35.64%1,873.6萬 | 365.63%1,787.1萬 | 4.71%2,838.9萬 | 8.09%8,878萬 | 147.91%2,871.8萬 | -21.22%2,911.2萬 | 1.27%383.8萬 | -9.04%2,711.2萬 | -47.63%8,213.7萬 | -64.99%1,158.4萬 |
基本每股收益 | -35.09%0.37 | 337.50%0.35 | 5.66%0.56 | 10.76%1.75 | 147.83%0.57 | -19.72%0.57 | 14.29%0.08 | -5.36%0.53 | -45.33%1.58 | -62.90%0.23 |
稀釋每股收益 | -35.19%0.35 | 312.50%0.33 | 4.00%0.52 | 10.07%1.64 | 140.91%0.53 | -18.18%0.54 | 14.29%0.08 | -5.66%0.5 | -44.61%1.49 | -62.07%0.22 |
每股派息 | 6.82%0.47 | 27.03%0.47 | 9.09%0.48 | 20.71%1.69 | 22.22%0.44 | 10.00%0.44 | 15.63%0.37 | 37.50%0.44 | 9.37%1.4 | 12.50%0.36 |
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | -- | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- |